The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes

The V617F activating point mutation in Jak2 is associated with a proportion of myeloproliferative disorders. In normal hematopoietic cells, Jak2 signals only when associated with a growth factor receptor, such as the erythropoietin receptor (EpoR). We sought to identify the molecular requirements fo...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Wernig, Gerlinde, Gonneville, Jeffrey R., Crowley, Brian J., Rodrigues, Margret S., Reddy, Mamatha M., Hudon, Heidi E., Walz, Christoph, Reiter, Andreas, Podar, Klaus, Royer, Yohan, Constantinescu, Stefan N., Tomasson, Michael H., Griffin, James D., Gilliland, D. Gary, Sattler, Martin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Hematology 2008
विषय:
Neoplasia
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2275031/
https://ncbi.nlm.nih.gov/pubmed/18216297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-102186
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन